News and Publications?height=270

News & publications

Related news & insights - James Went

Penningtons Manches Cooper advises Torpedo Factory Group Limited on its acquisition by Aukett Swanke
Posted: 02/05/2023
The corporate team at Penningtons Manches Cooper has acted for Torpedo Factory Group Limited, a leading audio, visual and stage technology provider to organisations in the UK and Europe, on its acquisition by AIM listed Aukett Swanke. Torpedo Factory Group is a technology systems integrator and services business operating primarily......>>
Penningtons Manches Cooper advises tech start-up EcoSync on further fundraise
Posted: 03/02/2023
The corporate team at Penningtons Manches Cooper has advised tech start-up EcoSync on securing additional funding as it continues its expansion, focusing on reducing energy usage in the built environment. EcoSync offers room-by-room energy services for commercial buildings across the UK, with a mission to reduce energy waste......>>
Penningtons Manches Cooper advises Celleron Therapeutics on the completion of its merger with Argonaut Therapeutics to form IngenOx Therapeutics
Posted: 18/01/2023
The corporate team at Penningtons Manches Cooper has advised University of Oxford spinout Celleron Therapeutics, a clinical-stage biopharmaceutical company advancing a pipeline of precision medicine drugs for advanced cancer indications, on the completion of its merger with Argonaut Therapeutics to form IngenOx Therapeutics......>>
Penningtons Manches Cooper advises Simply Sustainable on its majority investment from Agathos Management LLP
Posted: 04/01/2023
The corporate team at Penningtons Manches Cooper has advised the shareholders of Simply Sustainable, a London-headquartered ESG and sustainability consultancy known for its deep sustainability expertise, on the majority investment from Agathos Management LLP, a lower mid-market private equity firm......>>
Penningtons Manches Cooper advises Seloxium on its spin-out from Oxford University
Posted: 07/11/2022
The corporate team at Penningtons Manches Cooper has advised Seloxium on the completion of its spin-out from Oxford University and initial seed funding led by Oxford Science Enterprises in cooperation with Oxford University Innovation, the University’s technology transfer office......>>
Penningtons Manches Cooper advises Seedrs on $100 million acquisition by Republic
Posted: 08/09/2022
The corporate team at Penningtons Manches Cooper has advised Seedrs, Europe’s leading online private investment platform, on its completed acquisition by Republic for $100 million. This is a landmark transaction which creates a business working globally to transform the world of private investment......>>
Corporate team advises crop protection discovery company on £35 million funding round
Posted: 20/06/2022
The corporate team at Penningtons Manches Cooper has advised Oxford based moa Technology Ltd on the completion of their £35 million ($44 million) Series B financing round......>>
Penningtons Manches Cooper advises innovative fuel cell company Bramble Energy on £35 million Series B financing round
Posted: 16/02/2022
The corporate team at Penningtons Manches Cooper has advised Bramble Energy on the completion of their £35 million Series B financing round. The financing will allow Bramble Energy to roll out its portable power products globally, as well as continue to develop its liquid cooled fuel cell stack capability......>>
Penningtons Manches Cooper advises fusion energy company First Light Fusion on $45 million Series C financing round
Posted: 15/02/2022
The corporate team at Penningtons Manches Cooper has advised First Light Fusion on the completion of their $45 million Series C financing round. The new funding will be used to accelerate the development of First Light’s technology and to perform further design and engineering work on a First Of A Kind commercial fusion energy power plant based on their technology......>>
Penningtons Manches Cooper advises medtech business Orthox on $12.5 million Series A financing round
Posted: 11/02/2022
The corporate team at Penningtons Manches Cooper has advised Oxford University spin-out Orthox Limited on the completion of a further $4.3 million (£3.2 million) to close its $12.5 million (£9.2 million) Series A financing round. The financing will support further clinical trials of its lead product, FibroFix™, at Southmead Hospital Bristol, UK and in Budapest, Hungary.

1
2
3
4

Filter news & insights

Filter by keyword: Filter by expertise:

In this section

Media enquiries

Contact our press team on:

+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)

Useful links

Value

Contact an office

London (Head office)
+44 (0)20 7457 3000
Basingstoke
+44 (0)1256 407100
Birmingham
+44 (0)121 312 2560
Cambridge
+44 (0)1223 465465
Guildford
+44 (0)1483 791800
Oxford
+44 (0)1865 722106
Reading
+44 (0)118 982 2640

Madrid
+34 91 781 6670
Paris
+33 1 44 34 24 80
Piraeus
+30 210 361 4840
Singapore
+65 6438 4497

Sectors

Services for Business

Services for Individuals

Copyright

© 2023 Penningtons Manches Cooper LLP.
All rights reserved.
Website design by Frontmedia / Dynamic Pear

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority under number 419867.